Bli medlem
Bli medlem

Du är här


Mycronic AB: Redeye - Still masked potential in Mycronic

In the Q2 report released 14th of July, Mycronic showed an
unexpectedly strong profitability in Assembly Solutions and the
delivery of 3 advanced PG systems exceeded our expectations.
Following the report we have updated our short term earnings
estimates and the market growth forecasts. Read more and download the
Research Update by Viktor Westman at:

Become a member at Redeye to access the latest research on Life
Science and Tech companies.

This is a press release from Redeye - Research Powered Investment


Författare Cision

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.